Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells

Table 1 Effects of treatment with survivin-siRNA on cell cycle distribution and apoptosis 48 h after transfection

Groups	Cell cycle			Apoptosis rate
	G0/G1	S	G2/M
Untreated	38.21 ± 3.39	47.71 ± 2.73	14.00 ± 0.92	0.83 ± 0.34
Non-silencing	42.53 ± 2.78	43.28 ± 4.12	14.20 ± 2.90	1.08 ± 0.33
Sur-siRNA	88.60 ± 4.04b	12.00 ± 3.42b	0.10 ± 0.07b	3.56 ± 0.91b

Data are expressed as mean ± SD of the three experiments, sur-siRNA group vs non-silencing group,

^bP < 0.01; sur-siRNA group vs untreated group, ^bP < 0.01.